![Dissolution of Tartaric Acid Pellets](https://tapellets.com/wp-content/uploads/2022/06/video-icon-495x400.jpg)
![Weakly basic actives DoE parameter space](https://tapellets.com/wp-content/uploads/2022/07/parameter-space-495x400.jpg)
Water-insoluble weakly basic actives on tartaric acid beads – a DoE case study
Abstract
Yes, the headline is long, the overall topic not easy,…
![Dipyridamole capsule free pixabay](https://tapellets.com/wp-content/uploads/2022/06/hand-capsule-pixabay-free-3632914_1920-495x400.jpg)
Analytics of Dipyridamole Modified Release Capsules
Abstract on dipyridamole formulations
A robust headspace gas…
![Dabigatran Formulation for Oral Administration](https://tapellets.com/wp-content/uploads/2022/04/Dabigatran-Formulation-for-Oral-Administration-495x400.png)
Dabigatran Formulation for Oral Administration – an Evaluation
Abstract
Dabigatran etexilate mesylate is a pro-drug of Dabigatran…
![Pellet sizes for potential BSC Class IV MUPS and capsule formulations.](https://tapellets.com/wp-content/uploads/2022/02/Cellets_BCS_class_IV-495x400.png)
BSC Class IV APIs in oral formulations
APIs of BSC Class IV in oral formulations represent one of four…
![API_TAP_formulation](https://tapellets.com/wp-content/uploads/2021/03/API_TAP_formulation.png)
Influence of tartaric acid pellets on the release behavior of a basic drug
Abstract
The objective of this study is to investigate the influence…
![TAP_700_1](https://tapellets.com/wp-content/uploads/2021/03/TAP_700_1.png)
Tartaric acid starter pellets as pH-modifier for basic drugs
Introduction
We will introduce tartaric acid starter pellets…